X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (215) 215
Patent (20) 20
Publication (15) 15
Book Chapter (7) 7
Book / eBook (4) 4
Newspaper Article (4) 4
Book Review (2) 2
Conference Proceeding (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (96) 96
hematology (53) 53
index medicus (52) 52
middle aged (41) 41
oncology (41) 41
adult (36) 36
female (36) 36
male (35) 35
aged (29) 29
cancer (28) 28
chemotherapy (28) 28
neutropenia (24) 24
antifungal agents - therapeutic use (23) 23
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
medicine & public health (22) 22
chemistry (21) 21
infectious diseases (21) 21
acyclic or carbocyclic compounds (20) 20
chemical or physical processes, e.g. catalysis or colloidchemistry (20) 20
climate change mitigation technologies in the production orprocessing of goods (20) 20
general tagging of cross-sectional technologies spanning over several sections of the ipc (20) 20
general tagging of new technological developments (20) 20
metallurgy (20) 20
organic chemistry (20) 20
performing operations (20) 20
physical or chemical processes or apparatus in general (20) 20
separation (20) 20
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (20) 20
technologies or applications for mitigation or adaptation againstclimate change (20) 20
their relevant apparatus (20) 20
transporting (20) 20
treatment outcome (19) 19
adolescent (18) 18
liposomal amphotericin-b (18) 18
care and treatment (17) 17
microbiology (17) 17
mycoses (17) 17
prognosis (17) 17
stem-cell transplantation (16) 16
pharmacology & pharmacy (15) 15
transplantation (15) 15
analysis (14) 14
aspergillosis (14) 14
health aspects (14) 14
amphotericin b (13) 13
bone-marrow-transplantation (13) 13
medicine (13) 13
mortality (13) 13
aged, 80 and over (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
leukemia (12) 12
remission induction (12) 12
stem cells (12) 12
combined modality therapy (11) 11
diagnosis (11) 11
infection (11) 11
neutropenia - complications (11) 11
research (11) 11
risk factors (11) 11
therapy (11) 11
acute myeloid-leukemia (10) 10
anti-bacterial agents - therapeutic use (10) 10
cytarabine - administration & dosage (10) 10
fungal infections (10) 10
hematologic neoplasms - complications (10) 10
immunocompromised host (10) 10
lymphomas (10) 10
bone marrow transplantation (9) 9
double-blind (9) 9
drug therapy (9) 9
epidemiology (9) 9
fluconazole (9) 9
infections (9) 9
invasive pulmonary aspergillosis (9) 9
mycoses - drug therapy (9) 9
mycoses - prevention & control (9) 9
neutropenic patients (9) 9
pneumonia (9) 9
rituximab (9) 9
survival analysis (9) 9
treatment (9) 9
voriconazole (9) 9
caspofungin (8) 8
clinical trials (8) 8
echinocandins (8) 8
febrile neutropenia (8) 8
fever (8) 8
immunocompromised patients (8) 8
leukemia, myeloid, acute - drug therapy (8) 8
multicenter (8) 8
polymerase-chain-reaction (8) 8
prospective studies (8) 8
survival (8) 8
anti-infective agents - therapeutic use (7) 7
antifungal prophylaxis (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
colony-stimulating factor (7) 7
cyclophosphamide - administration & dosage (7) 7
disease-free survival (7) 7
fungal-infections (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9873, pp. 1203 - 1210
Summary Background Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of... 
Internal Medicine | SURVIVAL | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | II MULTICENTER | B-CELL | ADVANCED FOLLICULAR LYMPHOMA | CYCLOPHOSPHAMIDE | VINCRISTINE | NON-HODGKINS-LYMPHOMA | COMBINATION | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Nitrogen Mustard Compounds - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Vincristine - administration & dosage | Adult | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Treatment Outcome | Nitrogen Mustard Compounds - adverse effects | Disease-Free Survival | Bendamustine Hydrochloride | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Aged | Infusions, Intravenous | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Usage | Chemotherapy | Bendamustine | Patient outcomes | Lymphomas | Research | Drug therapy | Comparative analysis | Cancer | Antimitotic agents | Care and treatment | Antineoplastic agents | Analysis | Bone marrow | Hematology
Journal Article
2015, ISBN 3662440008
Infections are among the most frequent complications in patients with hematological malignancies and in those undergoing high-dose chemotherapy and autologous... 
Medicine | Hematology | Transplantation of organs, tissues, etc | Oncology
Web Resource
2015, ISBN 3662440008
Infections are among the most frequent complications in patients with hematological malignancies and in those undergoing high-dose chemotherapy and autologous... 
Medicine | Hematology | Transplantation of organs, tissues, etc | Oncology
Web Resource
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2008, Volume 46, Issue 12, pp. 1813 - 1821
Journal Article
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2009, Volume 63, Issue 1, pp. i27 - i30
Journal Article
Journal Article
Current Infectious Disease Reports, ISSN 1523-3847, 12/2011, Volume 13, Issue 6, pp. 510 - 516
Journal Article
Annals of Hematology, ISSN 0939-5555, 9/2014, Volume 93, Issue 9, pp. 1449 - 1456
Journal Article